Tianjin Hengyu Medical Technology
Tianjin hygea medical technology co.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 Valuation: €0.0 | round | |
* | CNY100m | Late VC | |
| Total Funding | 000k | ||
Horimedcare specializes in the development and manufacturing of advanced cardiovascular diagnostic imaging equipment, including Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS) systems. The company serves healthcare providers and medical institutions, focusing on the cardiovascular market. Horimedcare operates on a B2B (business-to-business) model, generating revenue through the sale of its proprietary imaging systems and related catheters. The company leverages its strong R&D capabilities and partnerships with scientific institutions to continuously innovate and improve its product offerings. By maintaining control over its intellectual property and manufacturing processes, Horimedcare ensures high-quality and reliable diagnostic tools for its clients.
Keywords: cardiovascular, OCT, IVUS, diagnostic imaging, proprietary technology, healthcare, medical institutions, R&D, catheters, B2B.